These Hedge Funds Held a Big Monday Winner

At least three hedge funds were among the top shareholders of a biopharma company that was up by double-digits amid the market’s meltdown.

Bihua Chen, founder of Cormorant Asset Management. (Alex Flynn/Bloomberg)

Bihua Chen, founder of Cormorant Asset Management.

(Alex Flynn/Bloomberg)

Finding stocks that finished in the green on Monday was sort of like playing Where’s Waldo.

One of the very few winners, though, was a stock whose top shareholders are dominated by hedge funds.

Shares of Atea Pharmaceuticals jumped more than 10 percent on Monday, closing at $28.94

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related